aniline mustard has been researched along with Benign Neoplasms in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Denny, WA; Palmer, BD; Pullen, SM; Wilson, WR | 1 |
Clarkson, GJ; Liu, J; Paterson, MJ; Prentice, AW; Sadler, PJ; Stavros, VG; Woolley, JM | 1 |
Chatzisideri, T; Dalezis, P; Katsamakas, S; Sarli, V; Thysiadis, S; Trafalis, D | 1 |
Ferry, DM; Helsby, NA; Patterson, AV; Pullen, SM; Wilson, WR | 1 |
Pruijn, FB; Wilson, WR | 1 |
Denny, WA; Helsby, NA; Hicks, KO; Hogg, A; Pullen, SM; Wilson, WR | 1 |
Bittar, ES; Grabstald, H; Smith, SW; Whitmore, W; Yagoda, A; Young, CW | 1 |
Wilman, DE | 1 |
8 other study(ies) available for aniline mustard and Benign Neoplasms
Article | Year |
---|---|
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
Topics: Alkylation; Aniline Compounds; Aniline Mustard; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chemistry, Physical; Half-Life; Molecular Structure; Neoplasms; Nitrogen Mustard Compounds; Oxidation-Reduction; Oxygen; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
A Concerted Redox- and Light-Activated Agent for Controlled Multimodal Therapy against Hypoxic Cancer Cells.
Topics: Aniline Mustard; Antineoplastic Agents; DNA, Mitochondrial; Humans; Hypoxia; Neoplasms; Oxidation-Reduction; Prodrugs; Reactive Oxygen Species | 2023 |
Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy.
Topics: A549 Cells; Amino Acid Sequence; Aniline Mustard; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Fluorouracil; Humans; Integrins; Magnetic Resonance Spectroscopy; MCF-7 Cells; Neoplasms; Oligopeptides; Peptides, Cyclic; Propionates | 2017 |
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.
Topics: Aniline Mustard; Antineoplastic Agents; Aziridines; Bystander Effect; Chromatography, High Pressure Liquid; Escherichia coli; Genetic Therapy; Genetic Vectors; Humans; Mass Spectrometry; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured | 2004 |
Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killing.
Topics: Aniline Mustard; Animals; Antineoplastic Agents; Cell Hypoxia; Mice; Neoplasms; Nitrogen Mustard Compounds; Prodrugs; Xanthenes; Xanthones | 1995 |
Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
Topics: Aniline Mustard; Animals; Aziridines; Bystander Effect; Cell Culture Techniques; Cricetinae; Genetic Therapy; Humans; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell beta-glucuronidase activity.
Topics: Aniline Mustard; Female; Glucuronidase; Histocytochemistry; Humans; Male; Neoplasms; Nitrogen Mustard Compounds | 1976 |
Prodrugs in cancer chemotherapy.
Topics: Altretamine; Aniline Mustard; Animals; Antineoplastic Agents; Azo Compounds; Biotransformation; Chemistry, Pharmaceutical; Cyclophosphamide; Dacarbazine; Drug Evaluation; Female; Galactosidases; Glucuronosyltransferase; Humans; Imidazoles; Liver; Male; Nausea; Neoplasms; Neoplasms, Experimental; Structure-Activity Relationship; Temozolomide; Vomiting | 1986 |